Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021

Loading...
Loading...

 

Upgrades

  • For CEVA Inc CEVA, Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year-ago quarter EPS of $0.11. At the moment, the stock has a 52-week-high of $83.95 and a 52-week-low of $29.50. CEVA closed at $42.40 at the end of the last trading period.
  • For Comerica Inc CMA, Truist Securities upgraded the previous rating of Hold to Buy. In the first quarter, Comerica showed an EPS of $2.43, compared to $0.46 from the year-ago quarter. At the moment, the stock has a 52-week-high of $79.84 and a 52-week-low of $27.84. Comerica closed at $77.88 at the end of the last trading period.
  • According to DA Davidson, the prior rating for AppFolio Inc APPF was changed from Underperform to Neutral. In the first quarter, AppFolio showed an EPS of $0.01, compared to $0.06 from the year-ago quarter. The current stock performance of AppFolio shows a 52-week-high of $186.59 and a 52-week-low of $113.68. Moreover, at the end of the last trading period, the closing price was at $127.36.
  • For Wynn Resorts Ltd WYNN, Citigroup upgraded the previous rating of Sell to Neutral. In the first quarter, Wynn Resorts showed an EPS of $2.41, compared to $3.54 from the year-ago quarter. The current stock performance of Wynn Resorts shows a 52-week-high of $143.88 and a 52-week-low of $67.54. Moreover, at the end of the last trading period, the closing price was at $125.73.
  • Truist Securities upgraded the previous rating for Texas Capital Bancshares Inc TCBI from Hold to Buy. In the first quarter, Texas Capital Bancshares showed an EPS of $1.33, compared to $1.39 from the year-ago quarter. The stock has a 52-week-high of $93.26 and a 52-week-low of $22.01. At the end of the last trading period, Texas Capital Bancshares closed at $69.14.
  • For ResMed Inc RMD, Citigroup upgraded the previous rating of Neutral to Buy. For the third quarter, ResMed had an EPS of $1.30, compared to year-ago quarter EPS of $1.29. The current stock performance of ResMed shows a 52-week-high of $224.43 and a 52-week-low of $149.16. Moreover, at the end of the last trading period, the closing price was at $193.17.
  • For ShockWave Medical Inc SWAV, B of A Securities upgraded the previous rating of Neutral to Buy. In the first quarter, ShockWave Medical showed an EPS of $0.68, compared to $0.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $169.00 and a 52-week-low of $37.76. ShockWave Medical closed at $134.80 at the end of the last trading period.
  • According to Stephens & Co., the prior rating for Centene Corp CNC was changed from Equal-Weight to Overweight. For the first quarter, Centene had an EPS of $1.63, compared to year-ago quarter EPS of $0.86. The stock has a 52-week-high of $72.31 and a 52-week-low of $53.60. At the end of the last trading period, Centene closed at $69.61.
  • For The Trade Desk Inc TTD, Truist Securities upgraded the previous rating of Hold to Buy. In the first quarter, Trade Desk showed an EPS of $1.41, compared to $0.50 from the year-ago quarter. The stock has a 52-week-high of $972.80 and a 52-week-low of $269.00. At the end of the last trading period, Trade Desk closed at $489.60.
  • For United States Steel Corp X, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. In the first quarter, United States Steel showed an EPS of No EPS Value , compared to $1.53 from the year-ago quarter. The stock has a 52-week-high of $29.97 and a 52-week-low of $6.58. At the end of the last trading period, United States Steel closed at $27.46.
  • According to BNP Paribas, the prior rating for GrubHub Inc GRUB was changed from Underperform to Neutral. GrubHub earned $0.56 in the first quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $85.53 and a 52-week-low of $44.60. GrubHub closed at $64.87 at the end of the last trading period.
  • According to Barclays, the prior rating for Elanco Animal Health Inc ELAN was changed from Underweight to Equal-Weight. In the first quarter, Elanco Animal Health showed an EPS of $0.37, compared to $0.13 from the year-ago quarter. The stock has a 52-week-high of $34.81 and a 52-week-low of $18.37. At the end of the last trading period, Elanco Animal Health closed at $32.25.
  • For Metalla Royalty & Streaming Ltd MTA, Roth Capital upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $13.50 and a 52-week-low of $4.58. Metalla Royalty closed at $9.52 at the end of the last trading period.
  • For Activision Blizzard Inc ATVI, BMO Capital upgraded the previous rating of Market Perform to Outperform. Activision Blizzard earned $0.84 in the first quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Activision Blizzard shows a 52-week-high of $104.53 and a 52-week-low of $66.59. Moreover, at the end of the last trading period, the closing price was at $93.17.
  • Loop Capital upgraded the previous rating for Shopify Inc SHOP from Hold to Buy. Interestingly, in the first quarter, Shopify's EPS was $2.01. At the moment, the stock has a 52-week-high of $1499.75 and a 52-week-low of $685.00. Shopify closed at $1079.57 at the end of the last trading period.
  • Goldman Sachs upgraded the previous rating for Univar Solutions Inc UNVR from Neutral to Buy. For the first quarter, Univar Solns had an EPS of $0.43, compared to year-ago quarter EPS of $0.31. The stock has a 52-week-high of $25.72 and a 52-week-low of $11.26. At the end of the last trading period, Univar Solns closed at $24.77.
  • Goldman Sachs upgraded the previous rating for Eastman Chemical Co EMN from Neutral to Buy. For the first quarter, Eastman Chemical had an EPS of $2.13, compared to year-ago quarter EPS of $2.03. The stock has a 52-week-high of $127.44 and a 52-week-low of $57.30. At the end of the last trading period, Eastman Chemical closed at $124.78.
  • Goldman Sachs upgraded the previous rating for DuPont de Nemours Inc DD from Neutral to Buy. In the first quarter, DuPont de Nemours showed an EPS of $0.91, compared to $0.84 from the year-ago quarter. At the moment, the stock has a 52-week-high of $87.27 and a 52-week-low of $41.83. DuPont de Nemours closed at $81.77 at the end of the last trading period.
  • According to JP Morgan, the prior rating for South Jersey Industries Inc SJI was changed from Underweight to Neutral. South Jersey Indus earned $1.26 in the first quarter, compared to $1.15 in the year-ago quarter. The current stock performance of South Jersey Indus shows a 52-week-high of $29.62 and a 52-week-low of $18.24. Moreover, at the end of the last trading period, the closing price was at $25.76.
  • According to Deutsche Bank, the prior rating for Mesa Air Group Inc MESA was changed from Hold to Buy. For the second quarter, Mesa Air Group had an EPS of $0.23, compared to year-ago quarter EPS of $0.05. The current stock performance of Mesa Air Group shows a 52-week-high of $17.40 and a 52-week-low of $2.80. Moreover, at the end of the last trading period, the closing price was at $10.90.
  • Jefferies upgraded the previous rating for Nike Inc NKE from Hold to Buy. In the third quarter, Nike showed an EPS of $0.90, compared to $0.78 from the year-ago quarter. The current stock performance of Nike shows a 52-week-high of $147.95 and a 52-week-low of $84.11. Moreover, at the end of the last trading period, the closing price was at $136.30.
  • According to Raymond James, the prior rating for AssetMark Financial Holdings Inc AMK was changed from Outperform to Strong Buy. For the first quarter, AssetMark Financial Hldgs had an EPS of $0.30, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $29.45 and a 52-week-low of $20.88. At the end of the last trading period, AssetMark Financial Hldgs closed at $22.97.
  • Evercore ISI Group upgraded the previous rating for Hawaiian Electric Industries Inc HE from Underperform to In-Line. In the first quarter, Hawaiian Electric Indus showed an EPS of $0.59, compared to $0.31 from the year-ago quarter. At the moment, the stock has a 52-week-high of $45.97 and a 52-week-low of $31.83. Hawaiian Electric Indus closed at $45.41 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • According to Piper Sandler, the prior rating for Tyson Foods Inc TSN was changed from Overweight to Neutral. For the second quarter, Tyson Foods had an EPS of $1.34, compared to year-ago quarter EPS of $0.77. The current stock performance of Tyson Foods shows a 52-week-high of $79.77 and a 52-week-low of $55.28. Moreover, at the end of the last trading period, the closing price was at $78.75.
  • According to Northland Capital Markets, the prior rating for ORBCOMM Inc ORBC was changed from Outperform to Market Perform. ORBCOMM earned $0.04 in the first quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.55 and a 52-week-low of $2.35. ORBCOMM closed at $11.23 at the end of the last trading period.
  • For The RealReal Inc REAL, BTIG downgraded the previous rating of Buy to Neutral. In the first quarter, The RealReal showed an EPS of $0.49, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $30.22 and a 52-week-low of $11.43. The RealReal closed at $20.31 at the end of the last trading period.
  • For 8x8 Inc EGHT, Craig-Hallum downgraded the previous rating of Buy to Hold. In the fourth quarter, 8x8 showed an EPS of $0.00, compared to $0.12 from the year-ago quarter. The current stock performance of 8x8 shows a 52-week-high of $39.17 and a 52-week-low of $13.51. Moreover, at the end of the last trading period, the closing price was at $28.16.
  • For Halozyme Therapeutics Inc HALO, Piper Sandler downgraded the previous rating of Overweight to Neutral. Halozyme Therapeutics earned $0.37 in the first quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Halozyme Therapeutics shows a 52-week-high of $56.40 and a 52-week-low of $22.11. Moreover, at the end of the last trading period, the closing price was at $46.10.
  • JP Morgan downgraded the previous rating for SmileDirectClub Inc SDC from Overweight to Neutral. SmileDirectClub earned $0.12 in the first quarter, compared to $0.28 in the year-ago quarter. The stock has a 52-week-high of $16.08 and a 52-week-low of $6.31. At the end of the last trading period, SmileDirectClub closed at $7.96.
  • For ITT Inc ITT, UBS downgraded the previous rating of Buy to Neutral. ITT earned $1.06 in the first quarter, compared to $0.80 in the year-ago quarter. The current stock performance of ITT shows a 52-week-high of $101.32 and a 52-week-low of $44.21. Moreover, at the end of the last trading period, the closing price was at $99.70.
  • According to Bryan Garnier, the prior rating for BioNTech SE BNTX was changed from Buy to Neutral. BioNTech earned $5.29 in the first quarter, compared to $0.26 in the year-ago quarter. The stock has a 52-week-high of $213.15 and a 52-week-low of $45.08. At the end of the last trading period, BioNTech closed at $202.35.
  • Baird downgraded the previous rating for Landstar System Inc LSTR from Outperform to Neutral. In the first quarter, Landstar System showed an EPS of $2.01, compared to $1.04 from the year-ago quarter. The stock has a 52-week-high of $182.63 and a 52-week-low of $101.14. At the end of the last trading period, Landstar System closed at $180.52.
  • For Heartland Express Inc HTLD, Baird downgraded the previous rating of Outperform to Neutral. In the first quarter, Heartland Express showed an EPS of $0.17, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $22.75 and a 52-week-low of $17.85. Heartland Express closed at $19.20 at the end of the last trading period.
  • Roth Capital downgraded the previous rating for Nautilus Inc NLS from Buy to Neutral. Nautilus earned $0.94 in the first quarter, compared to $0.08 in the year-ago quarter. The current stock performance of Nautilus shows a 52-week-high of $31.38 and a 52-week-low of $5.15. Moreover, at the end of the last trading period, the closing price was at $15.94.
  • Morgan Stanley downgraded the previous rating for Nuance Communications Inc NUAN from Overweight to Equal-Weight. For the second quarter, Nuance Communications had an EPS of $0.20, compared to year-ago quarter EPS of $0.21. The current stock performance of Nuance Communications shows a 52-week-high of $53.93 and a 52-week-low of $18.84. Moreover, at the end of the last trading period, the closing price was at $52.73.
  • CIBC downgraded the previous rating for Aurora Cannabis Inc ACB from Neutral to Underperformer. Aurora Cannabis earned $0.28 in the second quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.68 and a 52-week-low of $0.66. Aurora Cannabis closed at $8.40 at the end of the last trading period.
  • According to Scotiabank, the prior rating for Millicom International Cellular SA TIGO was changed from Outperform to Sector Perform. Millicom Intl Cellular earned $0.41 in the first quarter, compared to $1.21 in the year-ago quarter. The current stock performance of Millicom Intl Cellular shows a 52-week-high of $45.44 and a 52-week-low of $20.15. Moreover, at the end of the last trading period, the closing price was at $44.82.
  • Goldman Sachs downgraded the previous rating for Huntsman Corp HUN from Buy to Neutral. Huntsman earned $0.66 in the first quarter, compared to $0.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $32.35 and a 52-week-low of $13.86. Huntsman closed at $31.05 at the end of the last trading period.
  • For Dow Inc DOW, Goldman Sachs downgraded the previous rating of Buy to Neutral. For the first quarter, Dow had an EPS of $1.36, compared to year-ago quarter EPS of $0.59. At the moment, the stock has a 52-week-high of $70.60 and a 52-week-low of $30.90. Dow closed at $68.71 at the end of the last trading period.
  • Goldman Sachs downgraded the previous rating for LyondellBasell Industries NV LYB from Buy to Neutral. LyondellBasell Industries earned $3.18 in the first quarter, compared to $1.47 in the year-ago quarter. At the moment, the stock has a 52-week-high of $116.77 and a 52-week-low of $50.06. LyondellBasell Industries closed at $113.45 at the end of the last trading period.

See all analyst ratings downgrades.

 

Initiations

  • With an Outperform rating, SVB Leerink initiated coverage on Recursion Pharmaceuticals Inc RXRX. The price target seems to have been set at $33.00 for Recursion Pharmaceuticals. At the moment, the stock has a 52-week-high of $35.78 and a 52-week-low of $22.77. Recursion Pharmaceuticals closed at $23.04 at the end of the last trading period.
  • Roth Capital initiated coverage on Phunware Inc PHUN with a Buy rating. The price target for Phunware is set to $2.50. For the fourth quarter, Phunware had an EPS of $0.12, compared to year-ago quarter EPS of $0.10. At the moment, the stock has a 52-week-high of $3.34 and a 52-week-low of $0.60. Phunware closed at $1.23 at the end of the last trading period.
  • With a Buy rating, Needham initiated coverage on Blink Charging Co BLNK. The price target seems to have been set at $39.00 for Blink Charging. For the fourth quarter, Blink Charging had an EPS of $0.24, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $64.50 and a 52-week-low of $1.55. At the end of the last trading period, Blink Charging closed at $30.13.
  • Needham initiated coverage on Clean Energy Fuels Corp CLNE with a Buy rating. The price target for Clean Energy Fuels is set to $12.00. Clean Energy Fuels earned $0.01 in the first quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Clean Energy Fuels shows a 52-week-high of $19.79 and a 52-week-low of $1.82. Moreover, at the end of the last trading period, the closing price was at $8.78.
  • Needham initiated coverage on Beam Global BEEM with a Hold rating. In the fourth quarter, Beam Global earned $0.34. The current stock performance of Beam Global shows a 52-week-high of $75.90 and a 52-week-low of $10.53. Moreover, at the end of the last trading period, the closing price was at $26.30.
  • For Beam Therapeutics Inc BEAM, Redburn Partners initiated coverage, by setting the current rating at Buy. In the first quarter, Beam Therapeutics showed an EPS of $3.35, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $126.90 and a 52-week-low of $16.70. At the end of the last trading period, Beam Therapeutics closed at $64.12.
  • With a Sector Perform rating, RBC Capital initiated coverage on Penn Virginia Corp PVAC. The price target seems to have been set at $21.00 for Penn Virginia. Penn Virginia earned $0.39 in the first quarter, compared to $1.89 in the year-ago quarter. The current stock performance of Penn Virginia shows a 52-week-high of $20.18 and a 52-week-low of $5.50. Moreover, at the end of the last trading period, the closing price was at $17.49.
  • Jefferies initiated coverage on Biomea Fusion Inc BMEA with a Buy rating. The price target for Biomea Fusion is set to $26.00. At the moment, the stock has a 52-week-high of $22.22 and a 52-week-low of $15.15. Biomea Fusion closed at $16.63 at the end of the last trading period.
  • B of A Securities initiated coverage on Recursion Pharmaceuticals Inc RXRX with a Buy rating. The price target for Recursion Pharmaceuticals is set to $31.00. At the moment, the stock has a 52-week-high of $35.78 and a 52-week-low of $22.77. Recursion Pharmaceuticals closed at $23.04 at the end of the last trading period.
  • For TuSimple Holdings Inc TSP, Wolfe Research initiated coverage, by setting the current rating at Peer Perform. At the moment, the stock has a 52-week-high of $41.50 and a 52-week-low of $32.13. TuSimple Hldgs closed at $37.09 at the end of the last trading period.
  • Cantor Fitzgerald initiated coverage on Compass Pathways PLC CMPS with an Overweight rating. The price target for Compass Pathways is set to $71.00. In the fourth quarter, Compass Pathways showed an EPS of $0.52, compared to $0.90 from the year-ago quarter. The current stock performance of Compass Pathways shows a 52-week-high of $61.69 and a 52-week-low of $22.51. Moreover, at the end of the last trading period, the closing price was at $35.77.
  • DA Davidson initiated coverage on Karat Packaging Inc KRT with a Buy rating. The price target for Karat Packaging is set to $24.00. The current stock performance of Karat Packaging shows a 52-week-high of $20.00 and a 52-week-low of $16.68. Moreover, at the end of the last trading period, the closing price was at $18.08.
  • With an Overweight rating, JP Morgan initiated coverage on Akoya Biosciences Inc AKYA. The price target seems to have been set at $23.00 for Akoya Biosciences. The current stock performance of Akoya Biosciences shows a 52-week-high of $28.96 and a 52-week-low of $18.50. Moreover, at the end of the last trading period, the closing price was at $19.13.
  • JP Morgan initiated coverage on Biomea Fusion Inc BMEA with an Overweight rating. The price target for Biomea Fusion is set to $26.00. The current stock performance of Biomea Fusion shows a 52-week-high of $22.22 and a 52-week-low of $15.15. Moreover, at the end of the last trading period, the closing price was at $16.63.
  • With an Outperform rating, Oppenheimer initiated coverage on TuSimple Holdings Inc TSP. The price target seems to have been set at $55.00 for TuSimple Hldgs. At the moment, the stock has a 52-week-high of $41.50 and a 52-week-low of $32.13. TuSimple Hldgs closed at $37.09 at the end of the last trading period.
  • With a Neutral rating, JP Morgan initiated coverage on Recursion Pharmaceuticals Inc RXRX. The price target seems to have been set at $32.00 for Recursion Pharmaceuticals. The stock has a 52-week-high of $35.78 and a 52-week-low of $22.77. At the end of the last trading period, Recursion Pharmaceuticals closed at $23.04.
  • William Blair initiated coverage on Agilon Health Inc AGL with an Outperform rating. The stock has a 52-week-high of $34.47 and a 52-week-low of $26.50. At the end of the last trading period, Agilon Health closed at $33.43.
  • Desjardins initiated coverage on The Lion Electric Co LEV with a Buy rating. The price target for Lion Electric is set to $26.00. At the moment, the stock has a 52-week-high of $20.20 and a 52-week-low of $17.11. Lion Electric closed at $17.30 at the end of the last trading period.
  • Piper Sandler initiated coverage on Akoya Biosciences Inc AKYA with an Overweight rating. The price target for Akoya Biosciences is set to $28.00. The current stock performance of Akoya Biosciences shows a 52-week-high of $28.96 and a 52-week-low of $18.50. Moreover, at the end of the last trading period, the closing price was at $19.13.
  • Piper Sandler initiated coverage on Biomea Fusion Inc BMEA with an Overweight rating. The price target for Biomea Fusion is set to $27.00. The stock has a 52-week-high of $22.22 and a 52-week-low of $15.15. At the end of the last trading period, Biomea Fusion closed at $16.63.
  • With a Neutral rating, Goldman Sachs initiated coverage on Recursion Pharmaceuticals Inc RXRX. The price target seems to have been set at $34.00 for Recursion Pharmaceuticals. The current stock performance of Recursion Pharmaceuticals shows a 52-week-high of $35.78 and a 52-week-low of $22.77. Moreover, at the end of the last trading period, the closing price was at $23.04.
  • With an Overweight rating, Morgan Stanley initiated coverage on Akoya Biosciences Inc AKYA. The price target seems to have been set at $26.00 for Akoya Biosciences. The stock has a 52-week-high of $28.96 and a 52-week-low of $18.50. At the end of the last trading period, Akoya Biosciences closed at $19.13.
  • Oppenheimer initiated coverage on Coinbase Global Inc COIN with an Outperform rating. The price target for Coinbase Global is set to $434.00. The stock has a 52-week-high of $429.54 and a 52-week-low of $250.51. At the end of the last trading period, Coinbase Global closed at $293.45.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...